News: Intertek Expands GMP Capacity to Advance Inhaled Biologics, Vaccines and Complex Therapies

News: Intertek Expands GMP Capacity to Advance Inhaled Biologics, Vaccines and Complex Therapies

Giveaways

Information

Link: https://www.intertek.com/news/2025/intertek-expands-pharmaceutical-services-capacity-with-acquisition-of-new-facility-in-melbourn-cambridge/ Intertek’s new 29,000 sq ft GMP facility in Melbourn, Cambridge, UK significantly expands manufacturing and analytical capabilities for next generation inhaled and nasal drug development including inhaled biologics, mRNA and other advanced products, from early development through clinical manufacturing.
Intertek213Intertek Pharmaceutical Services – Bringing Quality, Safety and Sustainability to Life. Our bespoke, purpose-built GLP / GCP / GMP laboratories have supported developers and manufacturers for over 30 years by providing bioanalytical studies and advanced characterisation programs. We have worked on multiple studies involving cell or gene therapies, mRNA, plasmid DNA based products, and other advanced modalities. Our facility has been designed to handle recombinant genomic materials for the purposes of research and compliant testing, including specialist facilities for handling Class I and Class II Biological Agents. Intertek’s innovative bio/pharmaceutical services are delivered consistently with precision, pace, and passion, enabling you, our customer, to power ahead safely. Our solutions: • Cell and virus characterisation • Virology assays • Host cell and residual plasmid DNA • Cell-based assays / potency testing • General compendial testing • GMP analysis • GCP/GLP bioanalysis • ICH stability storage and testing • Method development and validation • QC release testing • Advanced delivery technology analytical support Find out more: www.intertek.com/pharmaceutical/biopharmaceuticals/gene-therapy-characterisation Contact us today: +44 (0)116 296 1620 | pharma.services@intertek.com Follow us: www.linkedin.com/showcase/intertek-pharma  ATMP Analytical Development Services & CMC Support Presentation Request | AAV Therapies: Developing Effective Analytical Strategies for In-Depth Empty vs Full Capsid Characterization > Brochure | Cell and Gene Therapies Analytical Development Services >

Log in

See all the content and easy-to-use features by logging in or registering!